Rocket Pharmaceuticals Files 8-K
Ticker: RCKTW · Form: 8-K · Filed: May 15, 2025 · CIK: 1281895
| Field | Detail |
|---|---|
| Company | Rocket Pharmaceuticals, Inc. (RCKTW) |
| Form Type | 8-K |
| Filed Date | May 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, disclosure, regulatory
TL;DR
Rocket Pharma filed an 8-K, but no juicy details yet.
AI Summary
Rocket Pharmaceuticals, Inc. filed an 8-K on May 15, 2025, reporting on other events and financial statements. The filing does not contain specific financial figures or details about the "other events" mentioned.
Why It Matters
This 8-K filing indicates Rocket Pharmaceuticals is making a regulatory disclosure, but lacks specific details on the nature of the events or financial updates.
Risk Assessment
Risk Level: low — The filing is a standard procedural disclosure without immediate financial or operational impact.
Key Players & Entities
- Rocket Pharmaceuticals, Inc. (company) — Registrant
- 0001140361-25-019326 (filing_id) — Accession Number
- May 15, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 001-36829 (file_number) — SEC File Number
- 9 Cedarbrook Drive, Cranbury, NJ 08512 (address) — Principal Executive Offices
- 646-440-9100 (phone_number) — Registrant's telephone number
FAQ
What specific events are being disclosed in this 8-K filing?
The filing indicates "Other Events" and "Regulation FD Disclosure" as items, but does not provide specific details about these events within the provided text.
When was this 8-K report filed?
The report was filed on May 15, 2025.
What is the principal executive office address for Rocket Pharmaceuticals, Inc.?
The principal executive offices are located at 9 Cedarbrook Drive, Cranbury, NJ 08512.
What is the SEC file number for Rocket Pharmaceuticals, Inc.?
The SEC file number is 001-36829.
What is the company's former name?
The company's former name was INOTEK PHARMACEUTICALS CORP.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 15, 2025 regarding ROCKET PHARMACEUTICALS, INC. (RCKTW).